Antidepressive Agents, Tricyclic
-
Subject Areas on Research
-
"Fibrositis" syndrome.
-
A comparison of inpatients with primary unipolar depression and depression secondary to anxiety.
-
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
-
A controlled study of cellular immune function in affective disorders before and during somatic therapy.
-
A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
-
A pilot study of mirtazapine in post-traumatic stress disorder.
-
A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
-
Adding a tricyclic antidepressant to a monoamine oxidase inhibitor.
-
Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome.
-
Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome.
-
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response.
-
Antidepressant therapy in patients with ischemic heart disease.
-
Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.
-
Antidepressant use in elderly medical inpatients: lessons from an attempted clinical trial.
-
Antidepressant use, depression, and survival in patients with heart failure.
-
Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats.
-
Anxiety, depression, and heart rate variability.
-
Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.
-
Best clinical practice: guidelines for managing major depression in primary medical care.
-
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
-
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
-
Clinical predictors of recurrence in depression.
-
Clinical trial evidence for treatment of depression in heart failure.
-
Concepts in pain management.
-
Consensus statement on depression, anxiety, and cardiovascular disease.
-
Delayed Cardiotoxicity From a Massive Nortriptyline Overdose Requiring Prolonged Treatment.
-
Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
-
Detection and treatment of major depression in older medically ill hospitalized patients.
-
Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport.
-
Dosing recommendations and prescribing patterns for depressed medically ill hospitalized older patients.
-
Dynamic systems theory as a paradigm for the study of change in psychotherapy: an application to cognitive therapy for depression.
-
Dyspepsia.
-
ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.
-
Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.
-
Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
-
Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
-
Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis.
-
Electrocardiogram Before Tricyclic Antidepressant Use: Minimal Impact in Pediatric Functional Gastrointestinal Disorders.
-
Emergency department analgesia without narcotics for adults with acute sickle cell pain crisis: case reports and review of crisis management.
-
Forms of atypical depression and their response to antidepressant drugs.
-
Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial.
-
MAOIs in the contemporary treatment of depression.
-
Marked differences in antidepressant use by race in an elderly community sample: 1986-1996.
-
Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.
-
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.
-
Neutrophil beta(2)-adrenoceptor function in major depression: G(s) coupling, effects of imipramine and relationship to treatment outcome.
-
Paroxetine in the treatment of generalised anxiety disorder.
-
Pharmacotherapy of generalized anxiety disorder.
-
Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.
-
Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome.
-
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
-
Prospective assessment of electroencephalographic sleep in remitted major depression.
-
Psychopharmacologic treatment of children and adolescents with anxiety disorders.
-
Rationale and design of a multicenter randomized clinical trial of vestibulodynia: understanding pathophysiology and determining appropriate treatments (vestibulodynia: UPDATe).
-
Respiratory Effects of the Atypical Tricyclic Antidepressant Tianeptine in Human Models of Opioid-induced Respiratory Depression.
-
Review of the use of mirtazapine in the treatment of depression.
-
Sensory neuromodulators in functional nausea and vomiting: predictors of response.
-
Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects.
-
Should physicians screen for depression in elderly medical inpatients?: Results of a decision analysis.
-
The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants.
-
The long-term treatment of panic disorder.
-
The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations.
-
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
-
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
-
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
-
Topical 5-fluorouracil is ineffective in the treatment of extensive alopecia areata.
-
Toward a rational pharmacotherapy of depression.
-
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
-
Treatment considerations for patients with neuropathic pain and other medical comorbidities.
-
Tricyclic antidepressant prescribing for nonpsychiatric disorders. An analysis based on data from the 1985 National Ambulatory Medical Care Survey.
-
Tricyclic antidepressants.
-
Tricyclic-induced akathisia in patients taking conjugated estrogens.
-
Vintage treatments for PTSD: a reconsideration of tricyclic drugs.
-
Keywords of People